Abstract 105P
Background
Cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-Seq) is a promising approach to assess non-invasive methylomics. Despite its cost-efficiency and accuracy, the setup and processing of cfMeDIP-Seq are technically challenging. The original protocol developed by Shen et al. in 2019 can now be partially automated, potentially improving reproducibility and yield.
Methods
We designed a pilot study to evaluate the performance of cfMeDIP-Seq under 4 library preparation conditions. We collected 4 K2EDTA and 4 PAXgene ccfDNA tubes (BD Vacutainer™) from the same healthy donor. We processed K2EDTA and PAXgene tubes within 2 and 6 hours of blood draw respectively, as previously described (Dameri et al., 2023). We used 10 ng of cfDNA for library preparation. Each condition underwent 2 parallel preparation procedures: one following the manual protocol described by Shen et al., and the other following a semi-automated version of the original protocol using the IP-Star® Compact instrument (Diagenode). We generated a total of 16 libraries, 4 for each condition, and sequenced them on Illumina NovaSeq 6000 device.
Results
The number of uniquely mapped reads was comparable (p-value = 0.8) between semi-automated and manually processed libraries, with an average of 19.9 MReads per sample. The percentage of duplicates was reduced (p-value = 0.0012) in semi-automated libraries (median = 32.88; IQR = 31.94-34.06) compared to manually prepared ones (median = 41.48; IQR = 35.61-42.53). Semi-automated libraries showed a longer mean insert size (255 bp) compared to manually processed libraries (243 bp) with a p-value < 0.01. Principal component analysis revealed no major differences between K2EDTA and PAXgene samples processed with the semi-automated protocol. We observed no significant differences across the 4 conditions in terms of GC content (47%, sd = 0.49).
Conclusions
In the present pilot study, we demonstrated that semi-automated library preparation outperformed the fully manual protocol, regardless of tube type but provided that K2EDTA were processed shortly after collection. Partial automation of fluidic handling seems extremely relevant to increase yield and quality of cfMeDIP-Seq experiments.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Associazione Italiana per la Ricerca sul Cancro (AIRC) and 5x1000 by Italian Ministry of Health.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
158P - Enhancing the communication of genomic results: Understanding patient and clinician perspectives
Presenter: Eleanor Johnston
Session: Cocktail & Poster Display session
Resources:
Abstract
159P - Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other NSCLC
Presenter: Nathan Merrill
Session: Cocktail & Poster Display session
Resources:
Abstract
160P - CICLADES-CE study: Genomic signatures detected in DNA from FFPE samples of patients with advanced or metastatic breast cancers treated with anti-aromatase and CDK4/6 inhibitors
Presenter: Margaux BETZ
Session: Cocktail & Poster Display session
Resources:
Abstract
161P - PDL1 expression and its relation to EML4-ALK gene variants in metastatic lung adenocarcinoma: A single-center real-world experience
Presenter: Santhosh Meedimale
Session: Cocktail & Poster Display session
Resources:
Abstract
163P - Impact of genomic sequencing data on treatment decisions in advanced breast cancer (ABC)
Presenter: Sviatoslav Chekhun
Session: Cocktail & Poster Display session
Resources:
Abstract
164P - Clinical utility of comprehensive molecular profiling tests for advanced gastrointestinal tumors
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract
165P - Evaluation of the mutational profile in patients with metastatic non-small cell lung carcinoma diagnosed in a tertiary hospital which was performed by NGS method
Presenter: Kankan Deka
Session: Cocktail & Poster Display session
Resources:
Abstract
166P - Targeted next-generation sequencing as reliable detection of genetic profile for cancer treatment to guide oncologists in Pakistan
Presenter: Zeeshan Ahmed
Session: Cocktail & Poster Display session
Resources:
Abstract
167P - Molecular analysis of gastrointestinal stromal tumor (GIST): The experience of Regina Elena National Cancer Institute
Presenter: Andrea Torchia
Session: Cocktail & Poster Display session
Resources:
Abstract
168P - Usefulness of liquid biopsy in the management of patients with advanced or metastatic pancreatic cancer
Presenter: Jorge Iranzo Barreira
Session: Cocktail & Poster Display session
Resources:
Abstract